Journal
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 35, Issue 2, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2021.101486
Keywords
primary bilateral macronodular adrenal hyperplasia; micronodular adrenal hyperplasia; primary pigmented nodular adrenal disease; Cushing's syndrome; unilateral adrenalectomy
Categories
Ask authors/readers for more resources
Primary bilateral adrenocortical hyperplasias are rare forms of pituitary ACTH-independent Cushing's syndrome, with treatment options including bilateral adrenalectomy and unilateral adrenalectomy, as well as medical therapies.
Primary bilateral adrenocortical hyperplasias are rare forms of pituitary ACTH-independent Cushing's syndrome (CS). They are divided between primary bilateral macronodular adrenal hyperplasia (PBMAH) and micronodular adrenal hyperplasia (MiBAH), which is subdivided in primary pigmented nodular adrenocortical disease (PPNAD) and isolated micronodular adrenocortical disease (i-MAD). One of the most debated aspects surrounding these entities is their most appropriate therapy. Although bilateral adrenalectomy (BA) has previously been the most utilized therapy for patients with overt CS, recent studies have indicated that unilateral adrenalectomy (UA) can beeffective inpatientswithPBMAHandsomewithMiBAHwith fewer long-termside effects. Medical therapies can also be used for bridging to surgery or rarely in the long-term for these patients. We reviewthe various degrees of CS resulting from PBMAH and MiBAH, with a special focus on their respective therapies including UA, taking into account the recent pathophysiological and genetics findings. (c) 2021 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available